Waters Corporation Stock Intrinsic Value – WATERS CORPORATION Reports Earnings Results for Third Quarter of FY2023

🌥️Earnings Overview

For the fiscal year 2023 quarter ending September 30, WATERS CORPORATION ($NYSE:WAT) reported total revenue of USD 711.7 million, an increase of 0.4% compared to the same quarter in the prior year. Net income, however, decreased by 13.7% to USD 134.6 million in the same period.

Share Price

On Tuesday, WATERS CORPORATION reported its earnings results for the third quarter of the fiscal year 2023. The stock opened at $242.0 and closed the day at $260.7, representing a 3.4% increase from its prior closing price of $252.2. The third quarter of 2023 saw a healthy increase in the company’s sales figures, driven by strong demand for their latest product, the Waters Edge System. The system was released to the public in early April and has already seen significant growth in sales, with over one million units sold in the first three months of availability.

WATERS CORPORATION also reported a strong increase in profit margins from the previous quarter, as well as a decrease in operating expenses. Overall, the earnings report from WATERS CORPORATION was positive and investors responded positively to the news. With strong sales and profits, WATERS CORPORATION looks poised to continue its success into the fourth quarter of 2023 and beyond. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Waters Corporation. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Waters Corporation. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Waters Corporation. More…

Key Ratios Snapshot

Some of the financial key ratios for Waters Corporation are shown below. More…

Analysis – Waters Corporation Stock Intrinsic Value

At GoodWhale, we have conducted an extensive analysis of WATERS CORPORATION‘s financials. Through our proprietary Valuation Line, we have determined that the fair value of WATERS CORPORATION share stands at around $337.5. However, WATERS CORPORATION stock is currently traded at $260.7, meaning that the stock is currently undervalued by 22.8%. As a result, we believe that this presents an opportune time for investors to buy WATERS CORPORATION shares. More…

Peers

Waters Corporation is an American analytical instrument manufacturing company that specializes in liquid chromatography, mass spectrometry, and thermal analysis instruments. It has annual sales of over $2 billion and employs more than 6,000 people worldwide. Its products are used in the life sciences, pharmaceutical, and chemical industries. Waters Corporation’s main competitors are IQVIA Holdings Inc, Agilent Technologies Inc, Vijaya Diagnostic Centre Ltd.

– IQVIA Holdings Inc ($NYSE:IQV)

The company’s market cap as of 2022 was 39.27B and its ROE was 21.52%. The company is a global provider of information, innovative technology solutions, and real-world insights that help customers improve their well-being. The company offers a broad range of products and services that enable customers to manage their health and wellbeing.

– Agilent Technologies Inc ($NYSE:A)

Agilent Technologies, Inc. is a provider of life sciences, diagnostics, and applied chemical markets solutions. It operates through three segments: Life Sciences and Applied Markets Group, Diagnostics and Genomics Group, and Agilent CrossLab Group. The Life Sciences and Applied Markets Group segment offers application solutions that include chromatography, mass spectrometry, chemical analysis, and cellular analysis. The Diagnostics and Genomics Group segment provides in vitro diagnostic products and services. The Agilent CrossLab Group segment offers a range of services and consumables. Agilent Technologies was founded in 1999 and is headquartered in Santa Clara, California.

– Vijaya Diagnostic Centre Ltd ($BSE:543350)

Vijaya Diagnostic Centre Ltd is a leading diagnostic centre in India with a market cap of 46.61B as of 2022. The company has a return on equity of 17.7%. The company offers a wide range of diagnostic services including X-rays, ultrasounds, MRI, and CT scans. The company also has a wide network of centres across India.

Summary

Investing analysis of Waters Corporation for the third quarter of fiscal year 2023 reveals a 0.4% year-on-year increase in total revenue to USD 711.7 million, accompanied by a 13.7% decrease in net income to USD 134.6 million. Despite the decrease in net income, the company’s stock price reacted positively, suggesting strong investor confidence. Overall, the performance of Waters Corporation appears to be stable and investors should maintain a positive outlook on the company’s prospects.